PD-1 and PD-L1 Inhibitors Definition

What is PD-1 and PD-L1 Inhibitors?

PD-1 and PD-L1 inhibitors are drugs used to treat certain types of cancer. They work by blocking the interaction between PD-1 and PD-L1, two proteins found on the surface of certain cancer cells. This prevents the cancer cells from hiding from the immune system, allowing the body's own immune system to attack and destroy them.


Synonyms of PD-1 and PD-L1 Inhibitors

Programmed Death-1 And Programmed Death-Ligand 1 Inhibitors, Checkpoint Inhibitors, Immunotherapy Inhibitors, Immune Checkpoint Inhibitors.


PD-1 and PD-L1 Inhibitors Trend 2023?

OJ Data Research recently released a new research paper on PD-1 and PD-L1 Inhibitors, which provides detailed information about the current state of the PD-1 and PD-L1 Inhibitors market, competitors, future market potential, customer base, and more.

Kindly click:https://oj-medical.com/Our-research/pd-1-and-pd-l1-inhibitors-market-20224051/